Grade: Pharmaceutical Grade
Factory Location: Lianyungang, Jiangsu, China.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Rolapitant is used for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
It is in R&D stage.